Skip to NavigationSkip to content

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

Published on: 03/11/21

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced the appointment of Dr Katarina Jelic Maiboe as Head of Regulatory Affairs, effective November 1, 2021.

HMNC Brain Health CEO, Benedikt con Braunmühl, said “Dr Maiboe is a proven leader in managing regulatory strategy and provides critical expertise as we progress our clinical pipeline and growth agenda. HMNC is committed to delivering critical mental health treatments through a novel precision psychiatry approach, and we are honoured to welcome her to our growing team.”

Dr Maiboe will play a critical role in driving HMNC’s commercial strategy and achieving key regulatory approvals.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches